Skip to main content
. 2017 Jun 22;1(6):538–549. doi: 10.1002/hep4.1060

Figure 1.

Figure 1

RNA dynamics and S282T emergence in SOF‐ or LDV/SOF‐treated patients. (A) Emergent S282T substitution in patient 1 (GT2b infection) and patient 2 (GT1b infection), who were treated with SOF monotherapy. (B) Emergent S282T substitution in patient 3 (GT1a infection) treated with LDV/SOF. (C) Emergent S282T substitution in three patients with GT1a infection (patients 4, 5, and 6) retreated with LDV/SOF. (D) Emergent S282T substitution in patients infected with non‐GT1 HCV (patients 7, 8, 9, and 10) who were treated with LDV/SOF.